Neurogene Inc. - Common Stock —— 季度现金流量表 (NASDAQ:NGNE) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

总资产 335.73 M315.3 M297.32 M287.83 M288.6 M263.14 M 负债总额 25.36 M23.51 M24.06 M22.29 M23.72 M25.36 M 权益总额 310.38 M291.8 M273.25 M265.54 M264.89 M237.78 M 负债及股东权益总额 335.73 M315.3 M297.32 M287.83 M288.6 M263.14 M 总债务 —————— 净债务 ——————

新闻

3 Best High-Risk, High-Reward Stocks to Buy Now, According to Analysts – 4/9/2026 - TipRanks.com

1 Top Stock to Buy Now with 350% Upside, 3/24/2026, According to Top Analysts - TipRanks.com

Stifel sees rare disease stocks gaining after FDA official exit

Netflix, Dell among market cap stock movers on Friday

Why Is Neurogene Stock Skyrocketing Friday? - Neurogene (NASDAQ:NGNE)

Neurogene股价因FDA突破性疗法认定飙升30%

Neurogene stock surges 30% on FDA breakthrough therapy status

FDA授予Neurogene瑞特综合征疗法突破性疗法认定

FDA grants breakthrough therapy status to Neurogene’s Rett drug

Stifel 重申 Neurogene 股票买入评级，认为其具有可行安全边际

Stifel reiterates Buy rating on Neurogene stock, cites viable safety margin

Neurogene在雷特综合征基因疗法试验中为多名患者给药